Yes I think we see that when test results are released like the effect against alk 6 WHO "Eskape" pathogens or other in vitro results. A few years ago that would have probably lit the fuse but it seems now the attitude is yeah we know you can kill pretty much any bacteria in isolation, what about tox in humans?
The sinusitis case was awesome start but realistically so far we have that and the doctor who self dosed327. Neither were "bankable" as not part of a clinical trial. First data that is usable for drug application will be a whole new playing field and price range I suspect. Any good human data surely will leave previous highs in the dust?
Yes I think we see that when test results are released like the...
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
58.0¢ |
Change
0.010(1.75%) |
Mkt cap ! $118.3M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 58.0¢ | 57.0¢ | $1.123K | 1.966K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 72111 | 57.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.0¢ | 1872 | 1 |
View Market Depth
| Last trade - 15.59pm 30/05/2024 (20 minute delay) ? |
| RCE (ASX) Chart |